2025-02-01 - Analysis Report
## Merck & Co Inc (MRK) Stock Report

**0. Key Figures Overview:**

* **Cumulative Return (MRK):** 63.14%
* **Cumulative Return (VOO/S&P 500):** 119.91%
* **Return Difference (MRK vs VOO):** -56.8%
* **Relative Divergence:** 6.7% (Indicates MRK's performance is relatively better than the VOO in the past, but not significantly based on past data)
* **Current Price:** $98.82
* **RSI:** 48.63
* **PPO:** 0.13
* **Expected Return (vs S&P 500, long-term):** 95.9%


**1. Performance Comparison & Company Overview:**

Merck & Co Inc is a leading pharmaceutical company.  Over the observed period, MRK significantly underperformed the S&P 500 (VOO), with a cumulative return difference of -56.8%.  While this suggests underperformance, the relative divergence of 6.7% suggests this underperformance is less extreme compared to its historical performance range.

**Alpha and Beta Analysis:**

The provided data shows fluctuating alpha and beta values. Alpha values show periods of outperformance and underperformance relative to the market (beta = 1). High beta values suggest higher volatility compared to the market.  The data lacks consistency to definitively define long-term trends, but it reveals considerable market sensitivity and periods where the stock's performance has diverged significantly from the market's average.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | -2.0% | 11.8% | -0.1 | 110.1 |
| 2016-2018  | 46.0% | 11.8% | 0.5 | 154.1 |
| 2017-2019  | 44.0% | 11.8% | 0.3 | 188.4 |
| 2018-2020  | 32.0% | 9.4% | 0.2 | 174.8 |
| 2019-2021  | 3.0% | 14.3% | 0.2 | 177.9 |
| 2020-2022  | 47.0% | 14.3% | 0.2 | 265.8 |
| 2021-2023  | 55.0% | 14.3% | 0.3 | 268.4 |
| 2022-2024  | 21.0% | 9.5% | 0.3 | 251.7 |
| 2023-2025  | -23.0% | 9.5% | 0.2 | 250.0 |


**2. Recent Price Movement:**

* **Closing Price:** $98.82
* **5-Day Moving Average:** $98.29
* **20-Day Moving Average:** $98.65
* **60-Day Moving Average:** $99.31

The price is slightly below all three moving averages, suggesting a potential short-term bearish trend.  The recent price change (-$0.13) indicates a minor downward movement.


**3. Technical Indicators and Expected Return:**

* **RSI:** 48.63 (Neutral; neither overbought nor oversold)
* **PPO:** 0.13 (Slightly positive, indicating potential upward momentum)
* **20-Day Relative Divergence Change:** +6.7% (Short-term upward trend)
* **Expected Return (long-term):** 95.9% (This high expected return needs to be scrutinized.  The basis of this calculation is not provided and requires further clarification.)


**4. Recent Earnings Analysis:**

The earnings data shows some fluctuation in EPS and revenue.  More analysis (comparing YoY and QoQ growth rates, considering seasonality) is needed to draw solid conclusions.  Note the duplicate entry for 2024-11-06.

| Date       | EPS  | Revenue      |
|------------|------|---------------|
| 2024-11-06 | 1.25 | $16.66B       |
| 2024-08-05 | 2.15 | $16.11B       |
| 2024-05-03 | 1.88 | $15.78B       |
| 2023-11-03 | 1.87 | $15.96B       |
| 2024-11-06 | 1.87 | $15.96B       |


**5. Financial Information:**

Both revenue and profitability metrics show relatively stable trends with minor fluctuations. ROE has also shown fluctuations. Further investigation is required to determine the underlying reasons behind this variability.

**Revenue and Profitability:**

| Quarter | Revenue     | Profit Margin |
|---------|-------------|---------------|
| 2024-09-30 | $16.66B    | 75.51%        |
| 2024-06-30 | $16.11B    | 76.76%        |
| 2024-03-31 | $15.78B    | 77.56%        |
| 2023-12-31 | $14.63B    | 73.26%        |
| 2023-09-30 | $15.96B    | 73.29%        |


**Capital and Profitability:**

| Quarter | Equity      | ROE      |
|---------|-------------|-----------|
| 2024-09-30 | $44.50B    | 7.09%    |
| 2024-06-30 | $43.58B    | 12.52%   |
| 2024-03-31 | $40.36B    | 11.80%   |
| 2023-12-31 | $37.58B    | -3.26%   |
| 2023-09-30 | $41.25B    | 11.50%   |


**6. Overall Analysis:**

MRK's performance has lagged behind the S&P 500 over the given period. While the short-term indicators suggest a slightly positive trend, the long-term outlook is less clear. The high projected long-term return needs further justification.  A deeper dive into the earnings data, considering YoY and QoQ growth, as well as a detailed analysis of the financial statements, is crucial to form a comprehensive investment opinion.  The highly fluctuating Alpha and Beta values highlight significant market sensitivity and periods of both outperformance and underperformance compared to the overall market.  The provided data, while informative, lacks sufficient depth for definitive conclusions about the company's long-term prospects.  Further research is required before making any investment decisions.
